Recommendation(s)

Acamprosate, disulfiram or naltrexone should be offered as part of treatment to reduce relapse to heavy alcohol use in alcohol dependent patients. The decision to use of acamprosate, disulfiram or naltrexone should be made taking into consideration patient preferences and availability.
Strength of recommendation: STRONG
Quality of evidence: VERY LOW

Disulfiram should be offered to motivated patients in whom medication adherence can be monitored by treatment personnel, carers or family members, and when non-specialist health care providers are alert to potential adverse effects, including the disulfiram-alcohol reaction.
Strength of recommendation: STRONG
Quality of evidence: VERY LOW